128 related articles for article (PubMed ID: 37955182)
61. Inhibition of retinoblastoma protein phosphorylation by myogenesis-induced changes in the subunit composition of the cyclin-dependent kinase 4 complex.
Wang J; Walsh K
Cell Growth Differ; 1996 Nov; 7(11):1471-8. PubMed ID: 8930396
[TBL] [Abstract][Full Text] [Related]
62. Differential utilization of cyclin D1 and cyclin D3 in the distinct mitogenic stimulations by growth factors and TSH of human thyrocytes in primary culture.
Paternot S; Dumont JE; Roger PP
Mol Endocrinol; 2006 Dec; 20(12):3279-92. PubMed ID: 16916940
[TBL] [Abstract][Full Text] [Related]
63. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity.
Fatrai S; Elghazi L; Balcazar N; Cras-Méneur C; Krits I; Kiyokawa H; Bernal-Mizrachi E
Diabetes; 2006 Feb; 55(2):318-25. PubMed ID: 16443763
[TBL] [Abstract][Full Text] [Related]
64. Cyclin D-CDK4 relieves cooperative repression of proliferation and cell cycle gene expression by DREAM and RB.
Schade AE; Oser MG; Nicholson HE; DeCaprio JA
Oncogene; 2019 Jun; 38(25):4962-4976. PubMed ID: 30833638
[TBL] [Abstract][Full Text] [Related]
65. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir I; Polyak K; Iavarone A; Massagué J
Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
[TBL] [Abstract][Full Text] [Related]
66. A selective cyclin-dependent kinase 4, 6 dual inhibitor, Ribociclib (LEE011) inhibits cell proliferation and induces apoptosis in aggressive thyroid cancer.
Lee HJ; Lee WK; Kang CW; Ku CR; Cho YH; Lee EJ
Cancer Lett; 2018 Mar; 417():131-140. PubMed ID: 29306020
[TBL] [Abstract][Full Text] [Related]
67. Cyclic AMP-dependent phosphorylation of cyclin D3-bound CDK4 determines the passage through the cell cycle restriction point in thyroid epithelial cells.
Paternot S; Coulonval K; Dumont JE; Roger PP
J Biol Chem; 2003 Jul; 278(29):26533-40. PubMed ID: 12730225
[TBL] [Abstract][Full Text] [Related]
68. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
[TBL] [Abstract][Full Text] [Related]
69. Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors.
Bisi JE; Sorrentino JA; Jordan JL; Darr DD; Roberts PJ; Tavares FX; Strum JC
Oncotarget; 2017 Jun; 8(26):42343-42358. PubMed ID: 28418845
[TBL] [Abstract][Full Text] [Related]
70. Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.
Rocha AS; Paternot S; Coulonval K; Dumont JE; Soares P; Roger PP
Mol Biol Cell; 2008 Nov; 19(11):4814-25. PubMed ID: 18799615
[TBL] [Abstract][Full Text] [Related]
71. Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.
Williamson EA; Burgess GS; Eder P; Litz-Jackson S; Boswell HS
Leukemia; 1997 Jan; 11(1):73-85. PubMed ID: 9001421
[TBL] [Abstract][Full Text] [Related]
72. Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.
Luo Y; Xu DQ; Dong HY; Zhang B; Liu Y; Niu W; Dong MQ; Li ZC
PLoS One; 2013; 8(2):e56774. PubMed ID: 23437233
[TBL] [Abstract][Full Text] [Related]
73. Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
Hinrichsen R; Hansen AH; Haunsø S; Busk PK
Cell Prolif; 2008 Oct; 41(5):813-29. PubMed ID: 18700867
[TBL] [Abstract][Full Text] [Related]
74. Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats.
Lu GF; Geng F; Deng LP; Lin DC; Huang YZ; Lai SM; Lin YC; Gui LX; Sham JSK; Lin MJ
Hypertension; 2022 Nov; 79(11):2465-2479. PubMed ID: 35997022
[TBL] [Abstract][Full Text] [Related]
75. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
[TBL] [Abstract][Full Text] [Related]
76. CDK4 activity in mouse embryos expressing a single D-type cyclin.
Ciemerych MA; Yu Q; Szczepanska K; Sicinski P
Int J Dev Biol; 2008; 52(2-3):299-305. PubMed ID: 18311721
[TBL] [Abstract][Full Text] [Related]
77. Ara-c induces cell cycle G1/S arrest by inducing upregulation of the INK4 family gene or directly inhibiting the formation of the cell cycle-dependent complex CDK4/cyclin D1.
Sun F; Li N; Tong X; Zeng J; He S; Gai T; Bai Y; Liu L; Lu K; Shen J; Han M; Lu C; Dai F
Cell Cycle; 2019 Sep; 18(18):2293-2306. PubMed ID: 31322047
[TBL] [Abstract][Full Text] [Related]
78. Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications.
Chen KH; Dasgupta A; Lin J; Potus F; Bonnet S; Iremonger J; Fu J; Mewburn J; Wu D; Dunham-Snary K; Theilmann AL; Jing ZC; Hindmarch C; Ormiston ML; Lawrie A; Archer SL
Circulation; 2018 Jul; 138(3):287-304. PubMed ID: 29431643
[TBL] [Abstract][Full Text] [Related]
79. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
80. Caenorhabditis elegans cyclin D/CDK4 and cyclin E/CDK2 induce distinct cell cycle re-entry programs in differentiated muscle cells.
Korzelius J; The I; Ruijtenberg S; Prinsen MB; Portegijs V; Middelkoop TC; Groot Koerkamp MJ; Holstege FC; Boxem M; van den Heuvel S
PLoS Genet; 2011 Nov; 7(11):e1002362. PubMed ID: 22102824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
